股票 › LTGO
拉蒂戈生物治疗 LTGO
美股市值排名 #3342
$12.60 −$0.41 (-3.15%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $12.30 -2.38%
开盘$13.18
昨收$13.01
当日区间$12.11 – $15.95
成交量556.1K
市值$835.37M
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$25.81M-0.2% YoY
净利润-$25.80M+0.1% YoY
摊薄每股收益-$0.43+26.9% YoY
自由现金流-$21.39M+0.9% YoY
经营现金流-$21.28M
营收，近4个季度
净利润，近4个季度
各季度摊薄每股收益
各季度自由现金流
盈利能力与资产负债表
资产收益率-171.6%
流动比率1.15
负债/资产比率526.3%
现金及投资$55.00M
总负债$30.55M
净现金（净负债）$24.46M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| 研发费用 | $21.23M | $17.63M | $99.53M | $22.92M | $18.69M |
| 销售及管理费用 | $4.58M | $5.80M | $10.86M | $2.82M | $2.82M |
| 非经营性利息收入 | $264,000.00 | $474,000.00 | $2.94M | $868,000.00 | $517,000.00 |
| 非经营性利息支出 | $251,000.00 | – | – | $0.00 | – |
| 其他收入（支出） | -$2,000.00 | $1,000.00 | -$1.72M | -$958,000.00 | $43,000.00 |
| 其他非经营性收入（支出） | -$2,000.00 | $1,000.00 | -$1.72M | -$958,000.00 | $43,000.00 |
| 税前利润 | -$25.80M | -$22.96M | -$109.17M | -$25.84M | -$20.95M |
| 净利润 | -$25.80M | -$22.96M | -$109.17M | -$25.84M | -$20.95M |
| 持续经营利润 | -$25.80M | -$22.96M | -$109.17M | -$25.84M | -$20.95M |
| 归属母公司净利润 | -$25.80M | -$22.96M | -$109.17M | -$25.84M | -$20.95M |
| 归属普通股股东净利润 | -$25.80M | -$22.96M | -$109.17M | -$25.84M | -$20.95M |
| 基本每股收益 | -$0.43 | -$0.52 | -$2.48 | -$0.59 | -$0.48 |
| 营业利润 | -$25.81M | -$23.44M | -$110.39M | -$25.75M | -$21.51M |
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $25.81M | $23.44M | $110.39M | $25.75M | $21.51M |
| -管理费用 | $4.58M | $5.80M | $10.86M | $2.82M | $2.82M |
| 摊薄每股收益 | -$0.43 | -$0.52 | -$2.48 | -$0.59 | -$0.48 |
| 非经营性利息净收入（支出） | $13,000.00 | $474,000.00 | $2.94M | $868,000.00 | $517,000.00 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2024 ANNUAL |
|---|---|---|---|---|
| 负债合计 | $340.84M | $303.16M | $307.19M | $152.46M |
| 流动负债合计 | $51.58M | $14.49M | $18.45M | $14.44M |
| 应付款 | $3.57M | $4.46M | $5.02M | $7.07M |
| -应付账款 | $3.57M | $4.46M | $5.02M | $7.07M |
| 一年内应计费用 | $8.78M | $8.63M | $8.67M | $4.71M |
| 短期债务及融资租赁负债 | $30.60M | $502,000.00 | $563,000.00 | $387,000.00 |
| -一年内到期债务 | $29.90M | – | – | – |
| -一年内到期融资租赁负债 | $705,000.00 | $502,000.00 | $563,000.00 | $387,000.00 |
| 其他流动负债 | $5.15M | – | – | $250,000.00 |
| 非流动负债合计 | $289.27M | $288.67M | $288.74M | $138.03M |
| 其他非流动资产 | $3.80M | $2.84M | $616,000.00 | $290,000.00 |
| 总资产 | $64.76M | $50.58M | $75.52M | $22.86M |
| 流动资产合计 | $59.20M | $46.84M | $73.83M | $21.16M |
| 现金及现金等价物与短期投资 | $55.00M | $42.18M | $69.44M | $17.92M |
| -现金及现金等价物 | $55.00M | $42.18M | $69.44M | $17.92M |
| 预付资产 | $4.00M | $4.47M | $4.20M | $3.25M |
| 受限现金 | $194,000.00 | $192,000.00 | $192,000.00 | $0.00 |
| 非流动资产合计 | $5.56M | $3.74M | $1.69M | $1.70M |
| 固定资产净值 | $1.76M | $900,000.00 | $1.07M | $1.41M |
| -固定资产原值 | $2.71M | $1.80M | $1.93M | $2.02M |
| 长期债务及融资租赁负债 | $648,000.00 | $52,000.00 | $127,000.00 | $464,000.00 |
| -长期融资租赁负债 | $648,000.00 | $52,000.00 | $127,000.00 | $464,000.00 |
| 留存收益 | -$291.89M | -$266.09M | -$243.13M | -$133.96M |
| 可转换优先证券 | $288.58M | $288.58M | $288.58M | $137.53M |
| 其他非流动负债 | $35,000.00 | $35,000.00 | $35,000.00 | $35,000.00 |
| 股东权益合计 | -$276.08M | -$252.58M | -$231.67M | -$129.60M |
| 股东权益 | -$276.08M | -$252.58M | -$231.67M | -$129.60M |
| 股本 | $0.00 | $0.00 | $0.00 | $0.00 |
| -普通股 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $15.81M | $13.51M | $11.46M | $4.37M |
| -累计折旧 | -$953,000.00 | -$901,000.00 | -$854,000.00 | -$605,000.00 |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| 筹资活动现金流 | $34.18M | -$230,000.00 | $149.50M | -$1,000.00 | $99.43M |
| 固定资产购置及出售净额 | -$110,000.00 | $0.00 | -$136,000.00 | -$33,000.00 | -$102,000.00 |
| 持续经营投资活动现金流净额 | -$110,000.00 | $0.00 | -$136,000.00 | -$33,000.00 | -$102,000.00 |
| 其他筹资费用净额 | -$974,000.00 | -$308,000.00 | – | – | – |
| -其他流动负债变动 | -$160,000.00 | -$136,000.00 | -$446,000.00 | -$94,000.00 | -$94,000.00 |
| -其他流动资产变动 | -$1.00M | -$2.26M | -$234,000.00 | $120,000.00 | $146,000.00 |
| -应付账款及应计费用变动 | $2.58M | -$3.59M | $4.18M | $2.53M | -$726,000.00 |
| -预付资产变动 | $472,000.00 | -$274,000.00 | -$979,000.00 | -$1.05M | -$1.11M |
| 营运资金变动 | $1.89M | -$6.26M | $2.52M | $1.51M | -$1.78M |
| 持续经营筹资活动现金流净额 | $34.18M | -$230,000.00 | $149.50M | -$1,000.00 | $99.43M |
| 优先股发行净额 | $0.00 | $0.00 | $149.38M | -$1,000.00 | $99.43M |
| 投资活动现金流净额 | -$110,000.00 | $0.00 | -$136,000.00 | -$33,000.00 | -$102,000.00 |
| 自由现金流 | -$21.39M | -$27.07M | -$97.69M | -$21.59M | -$21.26M |
| 期初现金余额 | $42.42M | $69.72M | $17.92M | $96.09M | $17.92M |
| 现金净变动 | $12.79M | -$27.30M | $51.80M | -$21.59M | $78.18M |
| 期末现金余额 | $55.21M | $42.42M | $69.72M | $74.50M | $96.09M |
| 股票期权行使所得 | $153,000.00 | $78,000.00 | $117,000.00 | $0.00 | $0.00 |
| 其他非现金项目 | $432,000.00 | $124,000.00 | $444,000.00 | $97,000.00 | $85,000.00 |
| 折旧、折耗与摊销 | $52,000.00 | $47,000.00 | $249,000.00 | $66,000.00 | $67,000.00 |
| 持续经营净利润 | -$25.80M | -$22.96M | -$109.17M | -$25.84M | -$20.95M |
| 持续经营经营活动现金流净额 | -$21.28M | -$27.07M | -$97.56M | -$21.56M | -$21.16M |
| 经营活动现金流 | -$21.28M | -$27.07M | -$97.56M | -$21.56M | -$21.16M |
| 普通股发行净额 | – | – | $0.00 | – | – |
暂无评论——快来第一个聊聊 LTGO。
登录后参与讨论。